Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.

González-Serna D, Carmona EG, Ortego-Centeno N, Simeón CP, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F; European GCA Consortium; European Scleroderma Group, Witte T, Neumann T, Holle J, Beretta L, Boiardi L, Emmi G, Cimmino MA, Vaglio A, Herrick AL, Denton CP, Salvarani C, Cid MC, Morgan AW, Fonseca C, González-Gay MA, Martín J, Márquez A.

PLoS One. 2018 Dec 26;13(12):e0209343. doi: 10.1371/journal.pone.0209343. eCollection 2018.

2.

Intracerebral Hemorrhage Secondary to Scorpion Toxin in the Northwest of Argentina; A Case Report.

Bordón L, Paredes W, Pacheco R, Graneros N, Tolosa C, Galarza G, Godoy DA.

Bull Emerg Trauma. 2018 Jul;6(3):253-256. doi: 10.29252/beat-060312.

3.

Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus.

González-Serna D, Ortiz-Fernández L, Vargas S, García A, Raya E, Fernández-Gutierrez B, López-Longo FJ, Balsa A, González-Álvaro I, Narvaez J, Gómez-Vaquero C, Sabio JM, García-Portales R, González-Escribano MF, Tolosa C, Carreira P, Kiemeney L, Coenen MJH, Witte T, Schneider M, González-Gay MÁ, Martín J.

Sci Rep. 2018 May 29;8(1):8195. doi: 10.1038/s41598-018-26573-4.

4.

First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

Rubio-Rivas M, Corbella X, Pestaña-Fernández M, Tolosa-Vilella C, Guillen-Del Castillo A, Colunga-Argüelles D, Trapiella-Martínez L, Iniesta-Arandia N, Castillo-Palma MJ, Sáez-Comet L, Egurbide-Arberas MV, Ortego-Centeno N, Freire M, Vargas-Hitos JA, Ríos-Blanco JJ, Todolí-Parra JA, Rodríguez-Carballeira M, Marín-Ballvé A, Segovia-Alonso P, Pla-Salas X, Madroñero-Vuelta AB, Ruiz-Muñoz M, Fonollosa-Pla V, Simeón-Aznar CP; RESCLE investigators, Autoimmune Diseases Study Group (GEAS), Callejas Moraga E, Calvo E, Carbonell C, Castillo MJ, Chamorro AJ, Colunga D, Corbella X, Egurbide MV, Espinosa G, Fonollosa V, Freire M, García Hernández FJ, González León R, Guillén Del Castillo A, Iniesta N, Lorenzo R, Madroñero AB, Marí B, Marín A, Ortego-Centeno N, Pérez Conesa M, Pestaña M, Pla X, Ríos Blanco JJ, Rodríguez Carballeira M, Rubio Rivas M, Ruiz Muñoz M, Sáez Comet L, Segovia P, Simeón CP, Soto A, Tarí E, Todolí JA, Tolosa C, Trapiella L, Vargas Hitos JA, Verdejo G.

Clin Rheumatol. 2018 Apr;37(4):999-1009. doi: 10.1007/s10067-017-3936-7. Epub 2017 Dec 7. Erratum in: Clin Rheumatol. 2018 Aug;37(8):2303-2304.

PMID:
29214548
5.

Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.

Tafur AJ, Caprini JA, Cote L, Trujillo-Santos J, Del Toro J, Garcia-Bragado F, Tolosa C, Barillari G, Visona A, Monreal M; RIETE Investigators.

Thromb Haemost. 2017 Jun 2;117(6):1192-1198. doi: 10.1160/TH16-11-0840. Epub 2017 Mar 9.

PMID:
28276571
6.

Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.

Blanco-Molina Á, Trujillo-Santos J, Pesavento R, Rosa V, Falgá C, Tolosa C, Mazzolai L, Sampériz Á, Duce R, Monreal M; RIETE Investigators.

Thromb Res. 2017 Mar;151 Suppl 1:S6-S10. doi: 10.1016/S0049-3848(17)30059-2.

PMID:
28262237
7.

Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort.

López-Isac E, Bossini-Castillo L, Palma AB, Assassi S, Mayes MD, Simeón CP, Ortego-Centeno N, Vicente E, Tolosa C, Rubio-Rivas M, Román-Ivorra JA, Beretta L, Moroncini G, Hunzelmann N, Distler JHW, Riemekasten G, de Vries-Bouwstra J, Voskuyl AE, Radstake TRDJ, Herrick A, Denton CP, Fonseca C, Martín J.

Arthritis Rheumatol. 2017 Jun;69(6):1337-1338. doi: 10.1002/art.40058. Epub 2017 May 9. No abstract available.

8.

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.

Ruiz-Irastorza G, Garcia M, Espinosa G, Caminal L, Mitjavila F, González-León R, Sopeña B, Canora J, Villalba MV, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L.

Lupus Sci Med. 2016 Aug 2;3(1):e000153. doi: 10.1136/lupus-2016-000153. eCollection 2016.

9.

A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.

Márquez A, Vidal-Bralo L, Rodríguez-Rodríguez L, González-Gay MA, Balsa A, González-Álvaro I, Carreira P, Ortego-Centeno N, Ayala-Gutiérrez MM, García-Hernández FJ, González-Escribano MF, Sabio JM, Tolosa C, Suárez A, González A, Padyukov L, Worthington J, Vyse T, Alarcón-Riquelme ME, Martín J.

Ann Rheum Dis. 2017 Jan;76(1):286-294. doi: 10.1136/annrheumdis-2016-209436. Epub 2016 May 18.

PMID:
27193031
10.

Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.

Ruiz-Irastorza G, García M, Espinosa G, Cabezas-Rodríguez I, Mitjavila F, González-León R, Sopeña B, Perales I, Pinilla B, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L; RELES, Autoimmune Diseases Study Group GEAS.

Clin Exp Rheumatol. 2016 May-Jun;34(3):466-72. Epub 2016 Feb 26.

PMID:
26940538
11.

Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice.

Giorgi-Pierfranceschi M, Di Micco P, Cattabiani C, Guida A, Pagán B, Morales Mdel V, Salgado E, Suriñach JM, Tolosa C, Monreal M; RIETE Investigators.

Medicine (Baltimore). 2015 Nov;94(47):e1915. doi: 10.1097/MD.0000000000001915.

12.

Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.

Cenit MC, Martínez-Florensa M, Consuegra M, Bonet L, Carnero-Montoro E, Armiger N, Caballero-Baños M, Arias MT, Benitez D, Ortego-Centeno N, de Ramón E, Sabio JM, García-Hernández FJ, Tolosa C, Suárez A, González-Gay MA, Bosch E, Martín J, Lozano F.

PLoS One. 2014 Nov 17;9(11):e113090. doi: 10.1371/journal.pone.0113090. eCollection 2014.

13.

Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.

Alba MA, Velasco C, Simeón CP, Fonollosa V, Trapiella L, Egurbide MV, Sáez L, Castillo MJ, Callejas JL, Camps MT, Tolosa C, Ríos JJ, Freire M, Vargas JA, Espinosa G; RESCLE Registry.

Medicine (Baltimore). 2014 Mar;93(2):73-81. doi: 10.1097/MD.0000000000000018.

14.

KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.

Bossini-Castillo L, Simeon CP, Beretta L, Broen J, Vonk MC, Callejas JL, Carreira P, Rodríguez-Rodríguez L, García-Portales R, González-Gay MA, Castellví I, Camps MT, Tolosa C, Vicente-Rabaneda E, Egurbide MV; Spanish Scleroderma Group, Schuerwegh AJ, Hesselstrand R, Lunardi C, van Laar JM, Shiels P, Herrick A, Worthington J, Denton C, Radstake TR, Fonseca C, Martin J.

Arthritis Res Ther. 2012 Dec 27;14(6):R273. doi: 10.1186/ar4124.

15.

Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.

Diaz-Gallo LM, Simeon CP, Broen JC, Ortego-Centeno N, Beretta L, Vonk MC, Carreira PE, Vargas S, Román-Ivorra JA, González-Gay MA, Tolosa C, López-Longo FJ, Espinosa G, Vicente EF, Hesselstrand R, Riemekasten G, Witte T, Distler JH, Voskuyl AE, Schuerwegh AJ, Shiels PG, Nordin A, Padyukov L, Hoffmann-Vold AM, Scorza R, Lunardi C, Airo P, van Laar JM, Hunzelmann N, Gathof BS, Kreuter A, Herrick A, Worthington J, Denton CP, Zhou X, Arnett FC, Fonseca C, Koeleman BP, Assasi S, Radstake TR, Mayes MD, Martín J; Spanish Scleroderma Group.

Ann Rheum Dis. 2013 Jul;72(7):1233-8. doi: 10.1136/annrheumdis-2012-202357. Epub 2012 Nov 21.

16.

Influence of the IL6 gene in susceptibility to systemic sclerosis.

Cénit MC, Simeón CP, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, Blanco FJ, Narvaez J, Tolosa C, Román-Ivorra JA, Gómez-García I, García-Hernández FJ, Gallego M, García-Portales R, Egurbide MV, Fonollosa V, García de la Peña P, López-Longo FJ, González-Gay MA; Spanish Scleroderma Group, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R, Fonseca C, Denton C, Nordin A, Palm Ø, van Laar JM, Hunzelmann N, Distler JH, Kreuter A, Herrick A, Worthington J, Koeleman BP, Radstake TR, Martín J.

J Rheumatol. 2012 Dec;39(12):2294-302. doi: 10.3899/jrheum.120506. Epub 2012 Oct 1.

PMID:
23027890
17.

A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.

Bossini-Castillo L, Simeon CP, Beretta L, Broen JC, Vonk MC, Ríos-Fernández R, Espinosa G, Carreira P, Camps MT, Castillo MJ, González-Gay MA, Beltrán E, Carmen Freire Md, Narváez J, Tolosa C, Witte T, Kreuter A, Schuerwegh AJ, Hoffmann-Vold AM, Hesselstrand R, Lunardi C, van Laar JM, Chee MM, Herrick A, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Martin J; Spanish Scleroderma Group.

Arthritis Res Ther. 2012 Apr 24;14(2):R85.

18.

Procalcitonin: a useful biomarker to discriminate infection after cardiopulmonary bypass in children.

Garcia IJ, Gargallo MB, Torné EE, Lasaosa FJ, Viñas AT, Tolosa CV, Rico AP.

Pediatr Crit Care Med. 2012 Jul;13(4):441-5. doi: 10.1097/PCC.0b013e31823890de.

PMID:
22422165
19.

The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.

Martin JE, Carmona FD, Broen JC, Simeón CP, Vonk MC, Carreira P, Ríos-Fernández R, Espinosa G, Vicente-Rabaneda E, Tolosa C, García-Hernández FJ, Castellví I, Fonollosa V, González-Gay MA, Sáez-Comet L, Portales RG, de la Peña PG, Fernández-Castro M, Díaz B, Martínez-Estupiñán L, Coenen M, Voskuyl AE, Schuerwegh AJ, Vanthuyne M, Houssiau F, Smith V, de Keyser F, De Langhe E, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Palm Ø, Chee MM, van Laar JM, Denton C, Herrick A, Worthington J, Koeleman BP, Radstake TR, Fonseca C, Martín J; Spanish Scleroderma Group.

Genes Immun. 2012 Feb;13(2):191-6. doi: 10.1038/gene.2011.72. Epub 2011 Oct 20.

PMID:
22012429
20.

No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis.

Carmona FD, Serrano-Lopera A, López-Isac E, Simeón CP, Carreira P, Rios-Fernandez R, Espinosa G, Camps MT, Navarrete N, González-Escribano MF, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, Beltrán E, Gómez-Garcia I, Fernández-Castro M, López-Longo FJ, García-Hernández FJ, Castellví I, Trapiella L, Fernández-Nebro A, García-Portales R, Egurbide MV, Fonollosa V, García de la Peña P, Pros A, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, González-Gay MA, Martín J.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5):895-6. Epub 2011 Oct 31. No abstract available.

PMID:
22011385
21.

Clinical presentation and outcome of venous thromboembolism in COPD.

Bertoletti L, Quenet S, Mismetti P, Hernández L, Martín-Villasclaras JJ, Tolosa C, Valdés M, Barrón M, Todolí JA, Monreal M; RIETE Investigators.

Eur Respir J. 2012 Apr;39(4):862-8. doi: 10.1183/09031936.00058811. Epub 2011 Sep 1.

22.

Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis.

Carmona FD, Simeon CP, Beretta L, Carreira P, Vonk MC, Ríos-Fernández R, Espinosa G, Navarrete N, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, García-Hernández FJ, Castellví I, Egurbide MV, Fonollosa V, González-Gay MA, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R, Shiels P, Fonseca C, Denton C, Nordin A, Palm Ø, Hoffmann-Vold AM, Airó P, Scorza R, Lunardi C, van Laar JM, Hunzelmann N, Kreuter A, Herrick A, Worthington J, Koeleman BP, Radstake TR, Martín J.

Ann Rheum Dis. 2011 Nov;70(11):2050-2. doi: 10.1136/ard.2010.148874. Epub 2011 May 13. No abstract available.

PMID:
21571730
23.

A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.

Bossini-Castillo L, Broen JC, Simeon CP, Beretta L, Vonk MC, Ortego-Centeno N, Espinosa G, Carreira P, Camps MT, Navarrete N, González-Escribano MF, Vicente-Rabaneda E, Rodríguez L, Tolosa C, Román-Ivorra JA, Gómez-Gracia I, García-Hernández FJ, Castellví I, Gallego M, Fernández-Nebro A, García-Portales R, Egurbide MV, Fonollosa V, de la Peña PG, Pros A, González-Gay MA, Hesselstrand R, Riemekasten G, Witte T, Coenen MJ, Koeleman BP, Houssiau F, Smith V, de Keyser F, Westhovens R, De Langhe E, Voskuyl AE, Schuerwegh AJ, Chee MM, Madhok R, Shiels P, Fonseca C, Denton C, Claes K, Padykov L, Nordin A, Palm O, Lie BA, Airó P, Scorza R, van Laar JM, Hunzelmann N, Kreuter A, Herrick A, Worthington J, Radstake TR, Martín J, Rueda B.

Ann Rheum Dis. 2011 Apr;70(4):638-41. doi: 10.1136/ard.2010.141838. Epub 2010 Dec 27. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1520.

PMID:
21187296
24.

Association of HLA class II genes with systemic sclerosis in Spanish patients.

Simeón CP, Fonollosa V, Tolosa C, Palou E, Selva A, Solans R, Armadans L, Moreno E, Marsal S, Vilardell M.

J Rheumatol. 2009 Dec;36(12):2733-6. doi: 10.3899/jrheum.090377. Epub 2009 Nov 2.

PMID:
19884273
25.

Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients.

Galanaud JP, Quenet S, Rivron-Guillot K, Quere I, Sanchez Muñoz-Torrero JF, Tolosa C, Monreal M; RIETE INVESTIGATORS.

J Thromb Haemost. 2009 Dec;7(12):2028-34. doi: 10.1111/j.1538-7836.2009.03629.x. Epub 2009 Sep 28.

26.

Analysis of temporal artery biopsies in an 18-year period at a community hospital.

Marí B, Monteagudo M, Bustamante E, Pérez J, Casanovas A, Jordana R, Tolosa C, Oristrell J.

Eur J Intern Med. 2009 Sep;20(5):533-6. doi: 10.1016/j.ejim.2009.05.002. Epub 2009 Jun 3.

PMID:
19712860
27.

Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.

Oristrell J, Bejarano G, Jordana R, Monteagudo M, Marí B, Casanovas A, Tolosa C.

Open Respir Med J. 2009 Jun 25;3:94-9. doi: 10.2174/1874306400903010094.

28.

[Relationship between reticulated platelets and megacaryocyte number in thrombocytopenic patients].

Monteagudo M, Lucchetti G, Amengual MJ, Muñoz L, Soler JA, Roig I, Tolosa C.

Med Clin (Barc). 2009 Jun 20;133(3):81-5. doi: 10.1016/j.medcli.2009.02.053. Epub 2009 Jun 9. Spanish.

PMID:
19515392
29.

Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus.

Sánchez E, Callejas-Rubio JL, Sabio JM, Gónzalez-Gay MA, Jimenez-Alonso J, Micó L, de Ramón E, Camps M, Suarez A, Gutierrez C, Garcia-Portales R, Tolosa C, Ortego-Centeno N, Sánchez-Román J, Garcia-Hernández FJ, Gónzalez-Escribano MF, Martin J.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2):267-71.

PMID:
19473567
30.

No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus.

Sánchez E, González-Gay MA, Callejas-Rubio JL, Ortego-Centeno N, Sabio JM, Jiménez-Alonso J, Micó L, Suarez A, Gutierrez C, de Ramón E, Camps M, Garcia-Portales R, Tolosa C, López-Nevot MA, Sánchez-Román J, Hernández FJ, González-Escribano MF, Martín J.

Lupus. 2009 Mar;18(3):230-4. doi: 10.1177/0961203308096256.

PMID:
19213861
31.

Reticulated platelets as a screening test to identify thrombocytopenia aetiology.

Monteagudo M, Amengual MJ, Muñoz L, Soler JA, Roig I, Tolosa C.

QJM. 2008 Jul;101(7):549-55. doi: 10.1093/qjmed/hcn047. Epub 2008 Apr 8.

PMID:
18400777
32.

Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry.

Monreal M, Falgá C, Valdés M, Suárez C, Gabriel F, Tolosa C, Montes J; Riete Investigators.

J Thromb Haemost. 2006 Sep;4(9):1950-6.

33.

Deep vein thrombosis and pulmonary embolism: the same disease?

Monreal M, Barba R, Tolosa C, Tiberio G, Todolí J, Samperiz AL; RIETE Investigators.

Pathophysiol Haemost Thromb. 2006;35(1-2):133-5.

PMID:
16855358
34.

Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients.

Casado E, Gratacós J, Tolosa C, Martínez JM, Ojanguren I, Ariza A, Real J, Sanjuán A, Larrosa M.

Ann Rheum Dis. 2006 Mar;65(3):385-90. Epub 2005 Aug 11.

35.

Multi-element analysis of road-deposited sediment in an urban drainage basin, Honolulu, Hawaii.

Sutherland RA, Tolosa CA.

Environ Pollut. 2000 Dec;110(3):483-95.

PMID:
15092827
36.

Discharge against medical advice at a general hospital in Catalonia.

Duñó R, Pousa E, Sans J, Tolosa C, Ruiz A.

Gen Hosp Psychiatry. 2003 Jan-Feb;25(1):46-50.

PMID:
12583928
37.

[40-year-old man with primary antiphospholipid syndrome].

Rodríguez Jornet A, Andreu FJ, Tolosa C.

Nefrologia. 2002;22(5):477-81. Spanish.

38.

Metal extraction from road sediment using different strength reagents: impact on anthropogenic contaminant signals.

Sutherland RA, Tack FM, Tolosa CA, Verloo MG.

Environ Monit Assess. 2001 Oct;71(3):221-42.

PMID:
11683229
39.

Idiopathic pylephlebitis and idiopathic sclerosing peritonitis in a man with protein S deficiency.

Sillero JM, Calvet X, Musulen E, Diaz-Ruiz MJ, Tolosa C, Pardo A, Corcuera A, Malet A, Font J.

J Clin Gastroenterol. 2001 Mar;32(3):262-5.

PMID:
11246360
40.

Characterization of selected element concentrations and enrichment ratios in background and anthropogenically impacted roadside areas.

Sutherland RA, Tolosa CA, Tack FM, Verloo MG.

Arch Environ Contam Toxicol. 2000 May;38(4):428-38.

PMID:
10787093
41.

Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.

Simeon CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C, Mearin F, Rodrigo MJ, Solans R, Lima J, Sampol G.

Ann Rheum Dis. 1997 Dec;56(12):723-8.

42.

Giant cell (temporal) arteritis and secondary renal amyloidosis: report of 2 cases.

Monteagudo M, Vidal G, Andreu J, Oristrell J, Tolosa C, Larrosa M, Casanovas A, Almirall J.

J Rheumatol. 1997 Mar;24(3):605-7.

PMID:
9058675
43.

[Tumorous lymphedema of the penis. Report of verrucous elephantiasis. A brief case. Preliminary note].

Luelmo J, Tolosa C, Prats J, Bella MR, Saez A, Pellicé C Jr.

Actas Urol Esp. 1995 Jul-Aug;19(7):585-7. Spanish.

PMID:
8815674
44.

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.

Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Franz J, Selva A, Ingelmo M, et al.

Am J Med. 1994 Jan;96(1):3-9.

PMID:
8304360
45.

Pseudomonas vesicularis bacteraemia.

Planes AM, Ramirez A, Fernandez F, Capdevila JA, Tolosa C.

Infection. 1992 Nov-Dec;20(6):367-8.

PMID:
1293060
46.

Monoclonal gammopathy in systemic lupus erythematosus.

Porcel JM, Ordi J, Tolosa C, Selva A, Castro-Salomo A, Vilardell M.

Lupus. 1992 Aug;1(4):263-4.

PMID:
1301990
47.

Skin graft: an effective solution for the pain and ulcers of cutaneous panarteritis.

Selva A, Ordi J, Vilardell M, Barquinero J, Tolosa C, Jordana R.

Clin Exp Rheumatol. 1990 Sep-Oct;8(5):519. No abstract available.

PMID:
1702045
48.

[Autoimmune hemolytic anemia and CREST syndrome].

Jordana R, Tolosa C, Selva A, Ordi J.

Med Clin (Barc). 1990 May 19;94(19):740-1. Review. Spanish.

PMID:
2201843
49.

[Nocardiosis in a carrier of antibodies against the human immunodeficiency virus].

Simeón CP, Balboa A, Tolosa C, Lu L.

Med Clin (Barc). 1990 May 12;94(18):719. Spanish. No abstract available.

PMID:
2388502
50.

[Danazol and autoimmune thrombocytopenia in systemic lupus erythematosus].

Selva A, Jordana R, Tolosa C, Ordi J.

Med Clin (Barc). 1990 Apr 14;94(14):557-8. Spanish. No abstract available.

PMID:
2355774

Supplemental Content

Loading ...
Support Center